Try our beta test site
2 studies found for:    181845 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Conditions: Kidney Neoplasm;   Lung Neoplasm;   Sarcoma;   Breast Neoplasm
Interventions: Biological: rh IL-12;   Biological: rh IL-2
2 Completed Ultra Low Dose Interleukin-2 in Healthy Volunteers
Condition: Hematologic Diseases
Interventions: Drug: Interleukin-2 (100,000 international units);   Drug: Interleukin-2 (200,000 international units)

Study has passed its completion date and status has not been verified in more than two years.